| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/07/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Stock Option (right to buy) | 16.3k | $26.00 | $422.6k | | 03/07/2023 |
| 02/28/2022 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Stock Option (right to buy) | 11.2k | $47.39 | $530.8k | | 02/28/2022 |
| 04/08/2021 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Stock Option (right to buy) | 2.3k | $4.42 | $10.3k | | 04/08/2021 |
| 04/08/2021 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Stock Option (right to buy) | 2.3k | $8.78 | $20.5k | | 04/08/2021 |
| 02/02/2021 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Stock Option (right to buy) | 13.5k | $49.32 | $665.8k | | 02/02/2021 |
| 02/28/2020 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Stock Option (right to buy) | 2.3k | $8.78 | $20.5k | | 02/28/2020 |
| 01/05/2020 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Stock Option (right to buy) | 10k | $59.80 | $598k | | 01/05/2020 |
| 03/04/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Stock Option (right to buy) | 2.3k | $4.04 | $9.5k | | 03/04/2019 |
| 01/23/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Stock Option (right to buy) | 10k | $42.40 | $424k | | 01/23/2019 |
| 01/07/2018 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Stock Option (Right to Buy) | 10k | $59.14 | $591.4k | | 01/07/2018 |
| 12/18/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Stock Option (Right to Buy) | 2.3k | $0.90 | $2.1k | | 12/18/2017 |
| 01/04/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Stock Option (right to buy) | 10k | $84.92 | $849.2k | | 01/04/2017 |
| 12/13/2016 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 8.7k | $75.00 | $652.5k | | 04/03/2014 |
| 12/12/2016 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 1.3k | $75.07 | $97.6k | | 04/03/2014 |
| 01/04/2016 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Stock Option (right to buy) | 15k | $86.15 | $1.3M | | 01/04/2016 |
| 04/21/2015 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Stock Option (right to buy) | 10k | $59.31 | $593.1k | | 04/21/2015 |
| 03/13/2015 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Option (right to buy) | 5k | $46.09 | $230.4k | | 03/13/2015 |
| 04/08/2014 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Stock Option (right to buy) | 4.7k | $12.67 | $59.3k | | 04/08/2014 |
| 04/03/2014 | EAGLE PHARMACEUTICALS, INC. | EGRX | Purchase | Common Stock | 4k | $12.79 | $50.5k | | 04/03/2014 |
| 02/18/2014 | EAGLE PHARMACEUTICALS, INC. | EGRX | Conversion | Series C Convertible Preferred Stock | 1.4k | $0.00 | $0 | | 02/18/2014 |
| 02/18/2014 | EAGLE PHARMACEUTICALS, INC. | EGRX | Conversion | Series B-1 Convertible Preferred Stock | 8.6k | $0.00 | $0 | | 02/18/2014 |
| 02/18/2014 | EAGLE PHARMACEUTICALS, INC. | EGRX | Conversion | Common Stock, $0.001 par value | 1.4k | $0.00 | $0 | | 02/18/2014 |
| 02/18/2014 | EAGLE PHARMACEUTICALS, INC. | EGRX | Conversion | Common Stock, $0.001 par value | 8.6k | $0.00 | $0 | | 02/18/2014 |